The need for improved risk stratification in chronic critical limb ischemia

Journal of Vascular Surgery

Volumn 60, Issue 6, 2014, Pages 1677-1685

  Chung, Jayer ^a   Modrall, J Gregory ^a   Valentine, R James ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDIFOLIGIDE; IXMYELOCEL T;

ACCOUNTABLE CARE ORGANIZATION; ANGIOPLASTY; ARTICLE; BONE MARROW DERIVED MONONUCLEAR CELL; BYPASS SURGERY; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL TRIAL (TOPIC); COMPARATIVE EFFECTIVENESS; COMPENSATION; COST EFFECTIVENESS ANALYSIS; CRITICAL LIMB ISCHEMIA; EXTERNAL VALIDITY; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICIAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; QUALITY CONTROL; RISK ASSESSMENT; SURVIVAL; VEIN GRAFT; WOUND HEALING; ADVERSE EFFECTS; AMPUTATION; CHRONIC DISEASE; CRITICAL ILLNESS; DECISION SUPPORT SYSTEM; ECONOMICS; ISCHEMIA; LIMB SALVAGE; MORTALITY; PATIENT SELECTION; RISK FACTOR; TREATMENT OUTCOME; VASCULAR SURGERY;

AMPUTATION; CHRONIC DISEASE; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HUMANS; ISCHEMIA; LIMB SALVAGE; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 84925169368     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2014.07.104     Document Type: Review

References (41)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
2. Conte MS, Geraghty PJ, Bradbury AW, Hevelone ND, Lipsitz SR, Moneta GL, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009;50:1462-73.
3. Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
4. Bell PR, Charlesworth D, DePalma RG, Eastcott HH, Eklof B, Gruss JD, et al. The definition of critical ischaemia of a limb. Br J Surg 1982;89:S2.
5. Marston WA, Davies SW, Armstrong B, Farber MA, Mendes RC, Fulton JJ, et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006;44:108-14.
6. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
7. Projections of the Population by Age and Sex for the United States: 2010-2050 (NP2008-T12). Table 12. Washington, D. C.: U. S. Census Bureau Population Division; 2008.
8. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013;127:e6-245.
9. Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006;43:742-51.
10. Nehler MR, Brass EP, Anthony R, Dormandy J, Jiao J, McNamara TO, et al; Circulase Investigators. Adjunctive parenteral therapy with lipoecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg 2007;45:953-60; discussion: 960-1.
11. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, et al; BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicenter, randomized controlled trial. Lancet 2005;366:1925-34.
12. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes GR, Gillespie I, et al; BASIL trial participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free or a balloon angioplasty-first revascularization strategy. J Vasc Surg 2010;51:5-17S.
13. Nicoloff AD, Taylor LM, McLafferty RB, Mondeta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 1998;27:256-63.
14. Goodney P, Beck A, Nagle J, Welch G, Zwolak R. National trends in lower extremity bypass surgery, endovascular interventions and major amputations. J Vasc Surg 2009;50:54-60.
15. Conrad MF, Crawford RS, Hackney LA, Paruchuri V, Abularrage CJ, Patel VI, et al. Endovascular management of patients with critical limb ischemia. J Vasc Surg 2011;53:1020-5.
16. Taylor SM, Kalbaugh CA, Blackhurst DW, Cass AL, Trent EA, Langan EM, et al. Determinants of functional outcome after revascularization for critical limb ischemia: an analysis of 1000 consecutive vascular interventions. J Vasc Surg 2006;44:747-56.
17. Chung J, Bartelson BB, Hiatt WR, Peyton BD, McLafferty RB, Hopley CW, et al. Wound healing and functional outcomes after infrainguinal bypass with reversed saphenous vein for critical limb ischemia. J Vasc Surg 2006;43:1183-90.
18. Taylor SM, Kalbaugh CA, Blackhurst DW, Hamontree SE, Cull DL, Messich HS, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients. J Vasc Surg 2005;42:227-35.
19. Powell RJ, Marston WA, Berceli SA, Guzman R, Henry TD, Longcore AT, et al. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI Trial. Mol Ther 2012;20:1280-6.
20. The World Bank. Health expenditure, total (% of GDP). Available at: http://data.worldbank.org/indicator/SH. XPD. TOTL. ZS. Accessed January 2, 2014.
21. Goodney PP, Fisher ES, Cambria RP. Roles for specialty societies and vascular surgeons in accountable care organizations. J Vasc Surg 2012;55:857-82.
22. Barshes NR, Belkin M. A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg 2011;213:552-66.
23. Luther M. Surgical treatment for chronic critical leg ischaemia: a 5 year follow-up of socioeconomic outcome. Eur J Vasc Endovasc Surg 1997;13:452-9.
24. Forbes JF, Adam DJ, Bell J, Fowkes FG, Gillespie I, Raab GM, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and costeffectiveness analysis. J Vasc Surg 2010;51:43-51S.
25. Barshes NR, Chambers JD, Cohen J, Belkin M. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg 2012;56:1015-24.
26. Zafar AM, Dhangana R, Murphy TP, Goodwin SC, Duszak R Jr, Ray CE Jr, et al. Lower-extremity endovascular interventions for Medicare beneficiaries: comparative effectiveness as a function of provider specialty. J Vasc Interv Radiol 2012;23:3-9e1-14.
27. Wallace JR, You T, Marone L, Chaer RA, Makaroun MS. Outcomes of endovascular lower extremity interventions depend more on indication that physician specialty. J Vasc Surg 2014;59:376-83.
28. Biancari F, Salenius JP, Heikkinen M, Luther M, Ylönen K, Lepäntalo M, et al. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg 2007;31:217-25.
29. Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg 2008;48:1464-71.
30. Schanzer A, Goodney PP, Li Y, Eslami M, Cronenwett J, Messina L, et al. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg 2009;50:769-75.
31. Arvela E, Söderström M, Korhonen M, Halmesmäki K, Albäck A, Lepäntalo M, et al. Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg 2010;52:1218-25.
32. Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes GR, Gillespie I, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making. J Vasc Surg 2010;51:52-68S.
33. Moxy PW, Brownrigg J, Kumar SS, Crate G, Holt PJ, Thompson MM, et al. The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores. J Vasc Surg 2013;57:1-8.
34. Mills JL, Conte MS, Armstrong DG, Pomposelli FB, Schanzer A, Sidawy AN. The Society for Vascular Surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 2014;59:220-34.e1-2.
35. Chung J, Timaran DA, Modrall JG, Ahn C, Timaran CH, Kirkwood ML, et al. Optimal medical therapy predicts amputationfree survival in chronic critical limb ischemia. J Vasc Surg 2013;58:972-80.
36. Kumar A, Brooks SS, Cavanaugh K, Zuckerman B. FDA perspective on objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg 2009;50:1474-6.
37. Taylor SM, Kalbaugh CA, Gray BH, Mackrell PJ, Langan EM 3rd, Cull DL, et al. The LEGS score: a proposed grading system to direct treatment of chronic lower extremity ischemia. Ann Surg 2003;237:812-8.
38. Androes MP, Kalbaugh CA, Taylor SM, Blackhurst DW, McClary GE, Gray BH, et al. Does a standardization tool to direct invasive therapy for symptomatic lower extremity peripheral arterial disease improve outcomes? J Vasc Surg 2004;40:907-15.
39. Gupta PK, Ramanan B, Lynch TG, Sundaram A, MacTaggart JN, Gupta H, et al. Development and validation of a risk calculator for prediction of mortality after infrainguinal bypass. J Vasc Surg 2012;56:372-9.
40. Meltzer AJ, Graham A, Connolly PH, Meltzer EC, Karwowski JK, Bush HL, et al. The Comprehensive Risk Assessment for Bypass (CRAB) facilitates efficient perioperative risk assessment for patients with critical limb ischemia. J Vasc Surg 2013;57:1186-95.
41. Rothman K. Biases in study design. In: Rothman K, editor. Epidemiology: an introduction. 1st ed. New York: Oxford University Press Inc; 2002. p. 94-112.